These results (such as the demarcation of the enzyme levels between high and not-high RA activity) lead us to consider the possibility of using ST3Gal1 and Neu3 levels of RA monocytes to distinguish between RA activity improvement and remission. This evidence concerns the gene NEU3 and rheumatoid arthritis.